20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Finasteride and BPH: Alleviating Symptoms of Enlarged Prostate

Benign prostatic hyperplasia (BPH), commonly referred to as an enlarged prostate, is a condition that affects a large proportion of aging men, causing significant urinary discomfort. Finasteride (CAS 98319-26-7) plays a crucial role in managing these symptoms by directly addressing the underlying hormonal influence. For pharmaceutical companies producing BPH medications, securing a dependable supply of Finasteride from reputable Chinese manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. is paramount.

Finasteride functions as a 5α-reductase inhibitor, specifically targeting the enzyme responsible for converting testosterone into dihydrotestosterone (DHT). DHT is a key factor in prostate growth. Elevated DHT levels within the prostate gland stimulate the proliferation of glandular and stromal tissue, leading to prostate enlargement. This enlargement can obstruct the urethra, causing a range of lower urinary tract symptoms (LUTS) associated with BPH.

By inhibiting 5α-reductase, Finasteride effectively lowers intraprostatic DHT concentrations. This reduction leads to a gradual decrease in prostate volume, typically by 20-30% over several months of consistent use. The shrinkage of the prostate relieves pressure on the urethra, improving urinary flow and mitigating symptoms such as urinary frequency, urgency, and nocturia. The demand to buy Finasteride China-based suppliers are well-positioned to meet, offering competitive pricing for this essential pharmaceutical ingredient.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to manufacturing Finasteride that meets strict pharmaceutical quality standards. Our products are characterized by high purity and consistent physical properties, ensuring their suitability for BPH treatments. We understand that for pharmaceutical formulations, the quality of the active pharmaceutical ingredient (API) is non-negotiable.

As a vital chemical intermediate, Finasteride's effectiveness in BPH management is well-established. Pharmaceutical companies that prioritize quality and reliability in their supply chain will find a valuable partner in NINGBO INNO PHARMCHEM CO.,LTD. Our commitment to excellence ensures that we can support your efforts in providing effective BPH treatments to patients worldwide.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Finasteride in Managing Androgenetic Alopecia

Next: The Global Market for Finasteride: Trends and Sourcing Strategies

All Rights Reserved